2023-08-01 |
2023-08-01 |
V
Vente
|
King Andrew James
Chief Scientific Officer
Dirigeant
|
1 168
-5.7%
39,03
45 586
USD
|
1 168
-5.7%
|
39,03
|
45 586
USD
|
|
2023-05-31 |
2023-05-30 |
VP
Vente planifiée
|
Greenman William Mariner
Administrateur non-exécutif
|
1 155
-4.7%
23,30
26 912
USD
|
1 155
-4.7%
|
23,30
|
26 912
USD
|
|
2023-04-26 |
2023-04-24 |
VP
Vente planifiée
|
DOBMEIER ERIC
President, CEO
Administrateur exécutif
|
23 800
-7.3%
21,58
513 528
USD
|
23 800
-7.3%
|
21,58
|
513 528
USD
|
|
2023-04-19 |
2023-04-17 |
V
Vente
|
Jerel Davis
Administrateur non-exécutif
|
295 808
-40.0%
20,75
6 138 223
USD
|
295 808
-40.0%
|
20,75
|
6 138 223
USD
|
|
2023-04-04 |
2023-04-04 |
VP
Vente planifiée
|
Krishnan Mahesh
Administrateur non-exécutif
|
924
-42.0%
23,01
21 261
USD
|
924
-42.0%
|
23,01
|
21 261
USD
|
|
2023-04-05 |
2023-04-03 |
VP
Vente planifiée
|
King Andrew James
Chief Scientific Officer
Dirigeant
|
5 000
-22.7%
23,34
116 718
USD
|
5 000
-22.7%
|
23,34
|
116 718
USD
|
|
2023-03-03 |
2023-03-01 |
V
Vente
|
Jerel Davis
Administrateur non-exécutif
|
36 751
-14.8%
22,75
836 085
USD
|
36 751
-14.8%
|
22,75
|
836 085
USD
|
|
2023-03-03 |
2023-03-01 |
V
Vente
|
Jerel Davis
Administrateur non-exécutif
|
123 249
-14.6%
22,75
2 803 915
USD
|
123 249
-14.6%
|
22,75
|
2 803 915
USD
|
|
2023-03-03 |
2023-03-01 |
V
Vente
|
Jerel Davis
Administrateur non-exécutif
|
240 000
-10.2%
22,75
5 460 000
USD
|
240 000
-10.2%
|
22,75
|
5 460 000
USD
|
|
2023-02-15 |
2023-02-10 |
V
Vente
|
King Andrew James
Chief Scientific Officer
Dirigeant
|
2 392
-10.9%
23,75
56 806
USD
|
2 392
-10.9%
|
23,75
|
56 806
USD
|
|
2023-02-15 |
2023-02-10 |
V
Vente
|
BJERKHOLT ERIC
Chief Financial Officer
Dirigeant
|
857
-2.2%
23,75
20 352
USD
|
857
-2.2%
|
23,75
|
20 352
USD
|
|
2023-02-15 |
2023-02-10 |
V
Vente
|
Frohlich Tom
Chief Operating Officer
Dirigeant
|
3 700
-2.4%
23,75
87 869
USD
|
3 700
-2.4%
|
23,75
|
87 869
USD
|
|
2023-02-15 |
2023-02-10 |
V
Vente
|
DOBMEIER ERIC
President, CEO
Administrateur exécutif
|
8 097
-2.6%
23,75
192 292
USD
|
8 097
-2.6%
|
23,75
|
192 292
USD
|
|
2023-02-02 |
2023-01-31 |
V
Vente
|
King Andrew James
Chief Scientific Officer
Dirigeant
|
3 244
-17.7%
24,68
80 069
USD
|
3 244
-17.7%
|
24,68
|
80 069
USD
|
|
2023-02-02 |
2023-01-31 |
V
Vente
|
Frohlich Tom
Chief Operating Officer
Dirigeant
|
4 566
-3.0%
24,68
112 700
USD
|
4 566
-3.0%
|
24,68
|
112 700
USD
|
|
2023-02-02 |
2023-01-31 |
V
Vente
|
BJERKHOLT ERIC
Chief Financial Officer
Dirigeant
|
2 891
-7.2%
24,68
71 357
USD
|
2 891
-7.2%
|
24,68
|
71 357
USD
|
|
2023-02-01 |
2023-01-31 |
V
Vente
|
DOBMEIER ERIC
President, CEO
Administrateur exécutif
|
7 688
-2.6%
24,68
189 757
USD
|
7 688
-2.6%
|
24,68
|
189 757
USD
|
|
2023-02-01 |
2023-01-30 |
VP
Vente planifiée
|
DOBMEIER ERIC
President, CEO
Administrateur exécutif
|
25 000
-8.4%
24,54
613 613
USD
|
25 000
-8.4%
|
24,54
|
613 613
USD
|
|
2023-01-04 |
2023-01-03 |
VP
Vente planifiée
|
King Andrew James
Chief Scientific Officer
Dirigeant
|
10 000
-50.0%
25,82
258 183
USD
|
10 000
-50.0%
|
25,82
|
258 183
USD
|
|
2022-12-15 |
2022-12-13 |
VP
Vente planifiée
|
Frohlich Tom
Chief Operating Officer
Dirigeant
|
10 000
-6.5%
25,00
250 005
USD
|
10 000
-6.5%
|
25,00
|
250 005
USD
|
|
2022-12-02 |
2022-12-01 |
VP
Vente planifiée
|
DOBMEIER ERIC
President, CEO
Administrateur exécutif
|
30 000
-11.0%
22,31
669 351
USD
|
30 000
-11.0%
|
22,31
|
669 351
USD
|
|
2022-12-02 |
2022-12-01 |
V
Vente
|
BJERKHOLT ERIC
Chief Financial Officer
Dirigeant
|
5 770
-14.9%
22,29
128 602
USD
|
5 770
-14.9%
|
22,29
|
128 602
USD
|
|
2022-11-09 |
2022-11-07 |
VP
Vente planifiée
|
Frohlich Tom
Chief Operating Officer
Dirigeant
|
10 000
-6.5%
22,16
221 642
USD
|
10 000
-6.5%
|
22,16
|
221 642
USD
|
|
2022-10-11 |
2022-10-06 |
V
Vente
|
Frohlich Tom
Chief Operating Officer
Dirigeant
|
7 360
-4.9%
19,69
144 933
USD
|
7 360
-4.9%
|
19,69
|
144 933
USD
|
|
2022-10-11 |
2022-10-06 |
V
Vente
|
King Andrew James
Chief Scientific Officer
Dirigeant
|
3 557
-22.2%
19,69
70 044
USD
|
3 557
-22.2%
|
19,69
|
70 044
USD
|
|
2022-09-06 |
2022-09-02 |
A
Achat
|
Thomas Dolca
Administrateur non-exécutif
|
300
+3.1%
21,20
6 360
USD
|
300
+3.1%
|
21,20
|
6 360
USD
|
|
2022-09-06 |
2022-09-02 |
A
Achat
|
Thomas Dolca
Administrateur non-exécutif
|
9 700
+inf%
21,22
205 834
USD
|
9 700
+inf%
|
21,22
|
205 834
USD
|
|
2022-08-05 |
2022-08-04 |
VP
Vente planifiée
|
King Andrew James
Chief Scientific Officer
Dirigeant
|
5 000
-45.9%
20,00
100 000
USD
|
5 000
-45.9%
|
20,00
|
100 000
USD
|
|
2022-07-13 |
2022-07-11 |
VP
Vente planifiée
|
King Andrew James
Chief Scientific Officer
Dirigeant
|
5 000
-45.9%
18,09
90 468
USD
|
5 000
-45.9%
|
18,09
|
90 468
USD
|
|
2022-06-01 |
2022-05-27 |
A
Achat
|
AKKARAJU SRINIVAS
Administrateur non-exécutif
|
570 000
+12.4%
14,00
7 980 000
USD
|
570 000
+12.4%
|
14,00
|
7 980 000
USD
|
|
2022-05-27 |
2022-05-25 |
A
Achat
|
DOBMEIER ERIC
President, CEO
Administrateur exécutif
|
5 000
+2.5%
13,03
65 148
USD
|
5 000
+2.5%
|
13,03
|
65 148
USD
|
|
2022-04-13 |
2022-04-11 |
VP
Vente planifiée
|
King Andrew James
Chief Scientific Officer
Dirigeant
|
5 000
-45.9%
15,36
76 812
USD
|
5 000
-45.9%
|
15,36
|
76 812
USD
|
|
2022-02-23 |
2022-02-18 |
VP
Vente planifiée
|
King Andrew James
Chief Scientific Officer
Dirigeant
|
2 500
-29.8%
13,00
32 500
USD
|
2 500
-29.8%
|
13,00
|
32 500
USD
|
|
2022-02-14 |
2022-02-11 |
V
Vente
|
BJERKHOLT ERIC
Chief Financial Officer
Dirigeant
|
895
-3.9%
12,74
11 403
USD
|
895
-3.9%
|
12,74
|
11 403
USD
|
|
2022-02-14 |
2022-02-11 |
V
Vente
|
Glicklich Alan
Chief Medical Officer
Dirigeant
|
2 391
-23.3%
12,74
30 464
USD
|
2 391
-23.3%
|
12,74
|
30 464
USD
|
|
2022-02-14 |
2022-02-11 |
V
Vente
|
King Andrew James
Chief Scientific Officer
Dirigeant
|
2 498
-22.9%
12,74
31 827
USD
|
2 498
-22.9%
|
12,74
|
31 827
USD
|
|
2022-02-14 |
2022-02-11 |
V
Vente
|
Frohlich Tom
Chief Operating Officer
Dirigeant
|
3 735
-2.6%
12,74
47 587
USD
|
3 735
-2.6%
|
12,74
|
47 587
USD
|
|
2022-02-11 |
2022-02-10 |
VP
Vente planifiée
|
King Andrew James
Chief Scientific Officer
Dirigeant
|
2 500
-37.9%
13,31
33 275
USD
|
2 500
-37.9%
|
13,31
|
33 275
USD
|
|
2022-01-05 |
2022-01-03 |
VP
Vente planifiée
|
Versant Venture Capital VII, L.P.
Large shareholder
|
92 000
-14.3%
16,00
1 472 018
USD
|
92 000
-14.3%
|
16,00
|
1 472 018
USD
|
|
2022-01-05 |
2022-01-03 |
VP
Vente planifiée
|
Versant Venture Capital VII, L.P.
Large shareholder
|
308 000
-14.2%
16,00
4 928 062
USD
|
308 000
-14.2%
|
16,00
|
4 928 062
USD
|
|
2022-01-05 |
2022-01-03 |
VP
Vente planifiée
|
Versant Venture Capital VII, L.P.
Large shareholder
|
600 000
-14.2%
16,00
9 600 120
USD
|
600 000
-14.2%
|
16,00
|
9 600 120
USD
|
|
2022-01-05 |
2022-01-03 |
VP
Vente planifiée
|
Jerel Davis
Administrateur non-exécutif
Large shareholder
|
92 000
-14.3%
16,00
1 472 018
USD
|
92 000
-14.3%
|
16,00
|
1 472 018
USD
|
|
2022-01-05 |
2022-01-03 |
VP
Vente planifiée
|
Jerel Davis
Administrateur non-exécutif
Large shareholder
|
308 000
-14.2%
16,00
4 928 062
USD
|
308 000
-14.2%
|
16,00
|
4 928 062
USD
|
|
2022-01-05 |
2022-01-03 |
VP
Vente planifiée
|
Jerel Davis
Administrateur non-exécutif
Large shareholder
|
600 000
-14.2%
16,00
9 600 120
USD
|
600 000
-14.2%
|
16,00
|
9 600 120
USD
|
|
2021-11-17 |
2021-11-15 |
A
Achat
|
AKKARAJU SRINIVAS
Administrateur non-exécutif
|
1 215 000
+36.0%
14,00
17 010 000
USD
|
1 215 000
+36.0%
|
14,00
|
17 010 000
USD
|
|
2021-11-12 |
2021-11-10 |
VP
Vente planifiée
|
Frohlich Tom
Chief Operating Officer
Dirigeant
|
6 230
-4.4%
15,48
96 440
USD
|
6 230
-4.4%
|
15,48
|
96 440
USD
|
|
2021-11-12 |
2021-11-09 |
VP
Vente planifiée
|
King Andrew James
Chief Scientific Officer
Dirigeant
|
5 000
-55.0%
13,53
67 660
USD
|
5 000
-55.0%
|
13,53
|
67 660
USD
|
|
2021-11-09 |
2021-11-08 |
VP
Vente planifiée
|
Frohlich Tom
Chief Operating Officer
Dirigeant
|
13 770
-8.9%
15,17
208 938
USD
|
13 770
-8.9%
|
15,17
|
208 938
USD
|
|
2021-11-09 |
2021-11-05 |
VP
Vente planifiée
|
Frohlich Tom
Chief Operating Officer
Dirigeant
|
5 000
-3.1%
14,00
70 000
USD
|
5 000
-3.1%
|
14,00
|
70 000
USD
|
|
2021-11-09 |
2021-11-05 |
VP
Vente planifiée
|
Frohlich Tom
Chief Operating Officer
Dirigeant
|
15 000
-8.6%
14,00
210 000
USD
|
15 000
-8.6%
|
14,00
|
210 000
USD
|
|
2021-06-17 |
2021-06-16 |
VP
Vente planifiée
|
Glicklich Alan
Chief Medical Officer
Dirigeant
|
20 000
-100.0%
16,35
326 968
USD
|
20 000
-100.0%
|
16,35
|
326 968
USD
|
|
2021-05-18 |
2021-05-14 |
A
Achat
|
DOBMEIER ERIC
President, CEO
Administrateur exécutif
|
1 000
+1.3%
14,44
14 440
USD
|
1 000
+1.3%
|
14,44
|
14 440
USD
|
|
2020-12-10 |
2020-12-09 |
A
Achat
|
DOBMEIER ERIC
President, CEO
Administrateur exécutif
|
2 000
+3.6%
13,08
26 150
USD
|
2 000
+3.6%
|
13,08
|
26 150
USD
|
|
2020-12-10 |
2020-12-08 |
A
Achat
|
DOBMEIER ERIC
President, CEO
Administrateur exécutif
|
2 000
+3.8%
13,24
26 483
USD
|
2 000
+3.8%
|
13,24
|
26 483
USD
|
|
2020-11-23 |
2020-11-23 |
A
Achat
|
DOBMEIER ERIC
President, CEO
Administrateur exécutif
|
929
+1.8%
13,67
12 699
USD
|
929
+1.8%
|
13,67
|
12 699
USD
|
|
2020-11-23 |
2020-11-20 |
A
Achat
|
DOBMEIER ERIC
President, CEO
Administrateur exécutif
|
571
+1.1%
13,69
7 817
USD
|
571
+1.1%
|
13,69
|
7 817
USD
|
|
2020-11-23 |
2020-11-19 |
A
Achat
|
DOBMEIER ERIC
President, CEO
Administrateur exécutif
|
500
+1.0%
13,50
6 750
USD
|
500
+1.0%
|
13,50
|
6 750
USD
|
|
2020-11-13 |
2020-11-11 |
A
Achat
|
DOBMEIER ERIC
President, CEO
Administrateur exécutif
|
2 500
+5.2%
13,75
34 375
USD
|
2 500
+5.2%
|
13,75
|
34 375
USD
|
|
2020-11-13 |
2020-11-10 |
A
Achat
|
DOBMEIER ERIC
President, CEO
Administrateur exécutif
|
2 000
+4.3%
13,86
27 720
USD
|
2 000
+4.3%
|
13,86
|
27 720
USD
|
|
2020-09-17 |
2020-09-15 |
V
Vente
|
Ferber Celeste
SVP, GC and Secretary
Dirigeant
|
2 396
-5.8%
2,39
5 731
USD
|
2 396
-5.8%
|
2,39
|
5 731
USD
|
|
2020-09-17 |
2020-09-15 |
V
Vente
|
Templeman Blaine
Chief Legal Officer
Dirigeant
|
12 369
-9.2%
2,39
29 585
USD
|
12 369
-9.2%
|
2,39
|
29 585
USD
|
|
2020-09-17 |
2020-09-15 |
V
Vente
|
ISAACS STEPHEN T
President and CEO
Administrateur exécutif
|
32 481
-10.4%
2,39
77 691
USD
|
32 481
-10.4%
|
2,39
|
77 691
USD
|
|
2020-08-11 |
2020-08-07 |
V
Vente
|
Nuyten Dimitry SA
Chief Medical Officer
Dirigeant
|
3 538
-29.5%
2,55
9 036
USD
|
3 538
-29.5%
|
2,55
|
9 036
USD
|
|
2020-08-11 |
2020-08-07 |
V
Vente
|
Ferber Celeste
SVP, GC and Secretary
Dirigeant
|
7 951
-16.2%
2,55
20 308
USD
|
7 951
-16.2%
|
2,55
|
20 308
USD
|
|
2020-08-11 |
2020-08-07 |
V
Vente
|
Templeman Blaine
Chief Legal Officer
Dirigeant
|
7 951
-5.6%
2,55
20 308
USD
|
7 951
-5.6%
|
2,55
|
20 308
USD
|
|
2020-02-26 |
2020-02-25 |
V
Vente
|
van Elsas Andrea
Chief Scientific Officer
Dirigeant
|
6 823
-1.5%
3,51
23 954
USD
|
6 823
-1.5%
|
3,51
|
23 954
USD
|
|
2020-01-06 |
2020-01-03 |
V
Vente
|
van Elsas Andrea
Chief Scientific Officer
|
73 311
-14.1%
1,19
87 108
USD
|
73 311
-14.1%
|
1,19
|
87 108
USD
|
|
2019-12-16 |
2019-12-12 |
V
Vente
|
Ferber Celeste
SVP, GC and Secretary
Dirigeant
|
408
-1.5%
1,16
475
USD
|
408
-1.5%
|
1,16
|
475
USD
|
|
2019-12-16 |
2019-12-12 |
V
Vente
|
van Elsas Andrea
Chief Scientific Officer
Dirigeant
|
2 192
-0.4%
1,16
2 550
USD
|
2 192
-0.4%
|
1,16
|
2 550
USD
|
|
2019-12-16 |
2019-12-12 |
V
Vente
|
ISAACS STEPHEN T
President and CEO
Administrateur exécutif
|
5 897
-2.0%
1,16
6 860
USD
|
5 897
-2.0%
|
1,16
|
6 860
USD
|
|
2019-12-16 |
2019-12-12 |
VP
Vente planifiée
|
Templeman Blaine
Chief Legal Officer
Dirigeant
|
1 264
-1.1%
1,16
1 470
USD
|
1 264
-1.1%
|
1,16
|
1 470
USD
|
|
2019-09-17 |
2019-09-13 |
V
Vente
|
van Elsas Andrea
Chief Scientific Officer
|
634
-0.1%
1,31
828
USD
|
634
-0.1%
|
1,31
|
828
USD
|
|
2019-09-17 |
2019-09-13 |
V
Vente
|
van Elsas Andrea
Chief Scientific Officer
|
17 959
-3.3%
1,31
23 451
USD
|
17 959
-3.3%
|
1,31
|
23 451
USD
|
|
2019-09-17 |
2019-09-13 |
V
Vente
|
Ferber Celeste
SVP, GC and Secretary
|
1 102
-3.9%
1,31
1 439
USD
|
1 102
-3.9%
|
1,31
|
1 439
USD
|
|
2019-09-17 |
2019-09-13 |
V
Vente
|
Ferber Celeste
SVP, GC and Secretary
|
1 392
-4.7%
1,31
1 818
USD
|
1 392
-4.7%
|
1,31
|
1 818
USD
|
|